CommScope (NASDAQ:COMM – Get Free Report) will release its earnings data before the market opens on Thursday, November 7th. Analysts expect CommScope to post earnings of $0.33 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.
CommScope (NASDAQ:COMM – Get Free Report) last issued its earnings results on Thursday, August 8th. The communications equipment provider reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.01). CommScope had a negative return on equity of 3.08% and a negative net margin of 31.24%. The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the previous year, the company posted $0.14 earnings per share. The company’s quarterly revenue was down 12.7% compared to the same quarter last year. On average, analysts expect CommScope to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
CommScope Trading Down 5.4 %
COMM stock opened at $6.42 on Tuesday. The company has a market cap of $1.39 billion, a price-to-earnings ratio of -0.79, a PEG ratio of 0.30 and a beta of 2.09. The firm has a 50 day moving average of $5.66 and a 200-day moving average of $3.10. CommScope has a 12-month low of $0.86 and a 12-month high of $7.07.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on COMM
CommScope Company Profile
CommScope Holding Company, Inc provides infrastructure solutions for communications, data center, and entertainment networks worldwide. The company operates through Connectivity and Cable Solutions (CCS); Outdoor Wireless Networks (OWN); Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS) segments.
Featured Articles
- Five stocks we like better than CommScope
- The How and Why of Investing in Gold Stocks
- Intel: Is Now the Time to Be Brave?Â
- Market Cap Calculator: How to Calculate Market Cap
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is Put Option Volume?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for CommScope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CommScope and related companies with MarketBeat.com's FREE daily email newsletter.